Alpha V integrin receptor antagonists

Details for Australian Patent Application No. 2001290884 (hide)

Owner Merck & Co., Inc.

Inventors Hutchinson, John H.; Li, Aiwen

Agent Spruson & Ferguson

Pub. Number AU-B-2001290884

PCT Pub. Number WO02/22123

Priority 60232222 13.09.00 US

Filing date 7 September 2001

Wipo publication date 26 March 2002

Acceptance publication date 15 December 2005

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

C07D 401/00 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 471/02 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/00 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

15 December 2005 Application Accepted

  Published as AU-B-2001290884

13 April 2006 Standard Patent Sealed

2 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001290885

2001290883-2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors